Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CREB3L4 is a transcription factor belonging to the basic leucine zipper (bZIP) family that is anchored to the endoplasmic reticulum membrane through a transmembrane domain[1][5]. It regulates gene expression via cAMP response elements and plays critical roles in multiple biological processes, notably as a negative regulator of adipocyte differentiation (blocking formation of fat cells), in spermatogenesis (development of male germ cells), and in the regulation of cell proliferation[1][2][3][4]. In humans, CREB3L4 expression is high in prostate tissue and is inducible by androgens, with demonstrated roles in prostate cancer cell growth and cell cycle progression[3][9]. CREB3L4 has also been implicated in the progression of breast and gastric cancers, and is correlated with aggressive tumor characteristics[1][6]. In mouse models, loss of CREB3L4 leads to reduced sperm number and increased adipocyte hyperplasia, implicating its importance in both fertility and metabolic disease[1][2]. The protein may also participate in the endoplasmic reticulum stress response and unfolded protein degradation[2][3][4]. At present, there are no approved drugs targeting CREB3L4, though its profile as a regulator of key pathways makes it a candidate for further therapeutic research in cancer and metabolic disease[2][3][9].
No approved drugs directly targeting CREB3L4 as of current knowledge. Potential mechanism if targeted: modulation of transcriptional activity, affecting adipogenesis or tumor cell proliferation pathways
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on cAMP responsive element binding protein 3-like 4 (CREB3L4).